Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Future Medicinal Chemistry|March 24, 2011
Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathwaySauveur-Michel Maira, Pascal Furet, Frédéric Stauffer
Expert Opinion on Therapeutic Targets|January 23, 2008
Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discoverySauveur-Michel Maira, Charles Voliva, Carlos Garcia-Echeverria
Biochemical Society Transactions|January 16, 2009
PI3K inhibitors for cancer treatment: where do we stand?Sauveur-Michel Maira, Frédéric Stauffer, Christian Schnell, et al.
The Journal of Biological Chemistry|December 7, 2002
Negative regulation of ERK and Elk by protein kinase B modulates c-Fos transcriptionIvana Galetic, Sauveur-Michel Maira, Mirjana Andjelkovic, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
Imidazo[4,5-c]quinolines as inhibitors of the PI3K/PKB-pathwayFrédéric Stauffer, Sauveur-Michel Maira, Pascal Furet, et al.
Genes & Development|July 23, 2013
Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndromeQi Wang, Thanh Von, Roderick Bronson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
PTEN-deficient cancers depend on PIK3CBSusan Wee, Dmitri Wiederschain, Sauveur-Michel Maira, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 17, 2013
Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditionsVincent A Potiron, Rym Abderrahmani, Rym Abderrhamani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2009
Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cellsSaskia M Brachmann, Irmgard Hofmann, Christian Schnell, et al.
Molecular Cancer Therapeutics|August 13, 2009
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomasTa-Jen Liu, Dimpy Koul, Tiffany LaFortune, et al.
Pageof 5